166 related articles for article (PubMed ID: 33277693)
21. Sentinel lymph node biopsy for melanoma: indications and rationale.
Phan GQ; Messina JL; Sondak VK; Zager JS
Cancer Control; 2009 Jul; 16(3):234-9. PubMed ID: 19556963
[TBL] [Abstract][Full Text] [Related]
22. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.
Bilimoria KY; Balch CM; Bentrem DJ; Talamonti MS; Ko CY; Lange JR; Winchester DP; Wayne JD
Ann Surg Oncol; 2008 Jun; 15(6):1566-76. PubMed ID: 18414952
[TBL] [Abstract][Full Text] [Related]
23. Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma.
El Sharouni MA; Witkamp AJ; Sigurdsson V; van Diest PJ
Ann Surg Oncol; 2019 May; 26(5):1494-1502. PubMed ID: 30719636
[TBL] [Abstract][Full Text] [Related]
24. Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival.
Moehrle M; Schippert W; Rassner G; Garbe C; Breuninger H
Dermatol Surg; 2004 Oct; 30(10):1319-28. PubMed ID: 15458529
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
26. Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: A retrospective study of surveillance, epidemiology, and end-result population-based data.
Chen J; Xu Y; Zhou Y; Wang Y; Zhu H; Shi Y
Oncotarget; 2016 Jul; 7(29):45671-45677. PubMed ID: 27344178
[TBL] [Abstract][Full Text] [Related]
27. Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy.
Doepker MP; Thompson ZJ; Harb JN; Messina JL; Puleo CA; Egan KM; Sarnaik AA; Gonzalez RJ; Sondak VK; Zager JS
J Surg Oncol; 2016 Jan; 113(1):98-102. PubMed ID: 26661407
[TBL] [Abstract][Full Text] [Related]
28. False-negative sentinel lymph node biopsy in head and neck melanoma.
Miller MW; Vetto JT; Monroe MM; Weerasinghe R; Andersen PE; Gross ND
Otolaryngol Head Neck Surg; 2011 Oct; 145(4):606-11. PubMed ID: 21659495
[TBL] [Abstract][Full Text] [Related]
29. Practice variation in Sentinel Lymph Node Biopsy for melanoma patients in different geographical regions in the Netherlands.
Verstijnen J; Damude S; Hoekstra HJ; Kruijff S; Ten Tije AJ; Louwman WJ; Bastiaannet E; Stuiver MM
Surg Oncol; 2017 Dec; 26(4):431-437. PubMed ID: 29113662
[TBL] [Abstract][Full Text] [Related]
30. Is sentinel node biopsy the standard of care in melanoma management? The opinions and practices of Australian specialists.
Anderson A; Love R; Chan J
Australas J Dermatol; 2012 May; 53(2):93-7. PubMed ID: 22497550
[TBL] [Abstract][Full Text] [Related]
31. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
[TBL] [Abstract][Full Text] [Related]
32. Is sentinel lymph node biopsy the standard of care for cutaneous head and neck melanoma?
Schmalbach CE; Bradford CR
Laryngoscope; 2015 Jan; 125(1):153-60. PubMed ID: 24986770
[TBL] [Abstract][Full Text] [Related]
33. Population-based assessment of sentinel lymph node biopsy in the management of cutaneous melanoma.
Ollek S; Minkova S; Taqi K; Chen L; Martinka M; Davis N; Hamilton T; Stuart H
Can J Surg; 2022; 65(3):E394-E403. PubMed ID: 35701006
[TBL] [Abstract][Full Text] [Related]
34. The 31-gene expression profile test informs sentinel lymph node biopsy decisions in patients with cutaneous melanoma: results of a prospective, multicenter study.
Yamamoto M; Sickle-Santanello B; Beard T; Essner R; Martin B; Bailey CN; Guenther JM
Curr Med Res Opin; 2023 Mar; 39(3):417-423. PubMed ID: 36617959
[TBL] [Abstract][Full Text] [Related]
35. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
Sekula-Gibbs SA; Shearer MA
Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
[TBL] [Abstract][Full Text] [Related]
36. The value of sentinel node mapping for staging melanoma.
Dijkstra B; Hill A; Kelly L; Prendegast M; McDermott E; O'Donnell M; Collins C; O'Higgins N
Ir Med J; 2001; 94(7):210-2. PubMed ID: 11693212
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma.
Beasley GM; Speicher P; Sharma K; Seigler H; Salama A; Mosca P; Tyler DS
J Am Coll Surg; 2014 Apr; 218(4):686-92. PubMed ID: 24529806
[TBL] [Abstract][Full Text] [Related]
38. Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and Cost.
Hu Y; Briggs A; Gennarelli RL; Bartlett EK; Ariyan CE; Coit DG; Brady MS
Ann Surg Oncol; 2020 Dec; 27(13):5248-5256. PubMed ID: 32514805
[TBL] [Abstract][Full Text] [Related]
39. The prognostic importance of sentinel lymph node biopsy in thin melanoma.
Ranieri JM; Wagner JD; Wenck S; Johnson CS; Coleman JJ
Ann Surg Oncol; 2006 Jul; 13(7):927-32. PubMed ID: 16788753
[TBL] [Abstract][Full Text] [Related]
40. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
